Libido as part of sexuality in female cancer survivors.
OBJECTIVE
To present the state of knowledge and a suggested program of research related to one part of sexual functioning in female cancer survivors: libido.


METHODS
Journal articles, monographs, and book chapters.


RESULTS
Sexuality is a broadly defined term with many components. Libido is a component of sexuality and is reviewed with respect to definition, physiology, and measurement. Evidence-based interventions also are discussed.


CONCLUSIONS
Most of the evidence related to enhancing libido involves testosterone, but this has not been tested in cancer survivors. Several clinical questions are yet to be answered regarding physiology as well as nonpharmacologic and pharmacologic interventions for enhancing libido.


CONCLUSIONS
Nurse researchers could add much to the evidence base on interventions for improving libido and, subsequently, sexual health. Implementing behavioral interventions to enhance libido would be an appropriate nursing function.
Barton
Debra
D
Mayo Clinic Cancer Center, Rochester, MN, USA. Barton.Debra@mayo.edu
Wilwerding
MaryBeth
M
Carpenter
Lisa
L
Loprinzi
Charles
C
D000928:Antidepressive Agents / Q000009:adverse effects; D001828:Body Image; D001971:Bromocriptine / Q000494:pharmacology; D004967:Estrogens / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects / Q000502:physiology; D008297:Male; D009294:Narcotics / Q000009:adverse effects; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing* / Q000503:physiopathology* / Q000523:psychology / Q000601:surgery; D010052:Ovariectomy; D012649:Self Concept; D019529:Sexuality / Q000187:drug effects / Q000502:physiology / Q000523:psychology; D017741:Survivors / Q000523:psychology; D013739:Testosterone / Q000008:administration & dosage
D000928:Antidepressive Agents; D004967:Estrogens; D009294:Narcotics; D001971:Bromocriptine; D013739:Testosterone